Drug Of Abuse Testing Services Market Size, Share & Trends Analysis Report By Drug (Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, LSD), By Region And Segment Forecasts, 2025 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Drug
                        1.2.2. Regional scope
                        1.2.3. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                            1.4.5.1. Data for primary interviews in North America
                            1.4.5.2. Data for primary interviews in Europe
                            1.4.5.3. Data for primary interviews in Asia Pacific
                            1.4.5.4. Data for primary interviews in Latin America
                            1.4.5.5. Data for Primary interviews in Middle East & Africa
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                        1.7.1. Commodity flow analysis (Model 1)
                        1.7.2. Approach 1: Commodity flow approach
                        1.7.3. Volume price analysis (Model 2)
                        1.7.4. Approach 2: Volume price analysis
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Drug outlook
                        2.2.2. Regional outlook
                    2.3. Competitive Insights
Chapter 3. Drug Of Abuse Testing Services Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                            3.2.1.1. High prevalence of substance abuse & growing demand for its treatment
                            3.2.1.2. Increase in government initiatives to monitor substance abuse
                            3.2.1.3. Stringent law mandating alcohol and drug testing
                        3.2.2. Market restraint analysis
                            3.2.2.1. Drug testing is considered a violation of privacy rights in some countries
                    3.3. Drug Of Abuse Testing Services Market Analysis Tools
                        3.3.1. Industry Analysis – Porter’s
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
Chapter 4. Drug Of Abuse Testing Services Market: Drug Estimates & Trend Analysis
                    4.1. Drug Market Share, 2024 & 2030
                    4.2. Segment Dashboard
                    4.3. Global Drug Of Abuse Testing Services Market by Drug Outlook
                    4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                        4.4.1. Alcohol
                            4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
                        4.4.2. Cannabis/Marijuana
                            4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.3. Cocaine
                            4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.4. Opioids
                            4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.5. Amphetamine & Methamphetamine
                            4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.6. LSD
                            4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                        4.4.7. Others
                            4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Drug Of Abuse Testing Services Market: Regional Estimates & Trend Analysis
                    5.1. Regional Market Share Analysis, 2024 & 2030
                    5.2. Regional Market Dashboard
                    5.3. Global Regional Market Snapshot
                    5.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
                    5.5. North America
                        5.5.1. U.S.
                            5.5.1.1. Key country dynamics
                            5.5.1.2. Regulatory framework/ reimbursement structure
                            5.5.1.3. Competitive scenario
                            5.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
                        5.5.2. Canada
                            5.5.2.1. Key country dynamics
                            5.5.2.2. Regulatory framework/ reimbursement structure
                            5.5.2.3. Competitive scenario
                            5.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
                        5.5.3. Mexico
                            5.5.3.1. Key country dynamics
                            5.5.3.2. Regulatory framework/ reimbursement structure
                            5.5.3.3. Competitive scenario
                            5.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million
                    5.6. Europe
                        5.6.1. UK
                            5.6.1.1. Key country dynamics
                            5.6.1.2. Regulatory framework/ reimbursement structure
                            5.6.1.3. Competitive scenario
                            5.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
                        5.6.2. Germany
                            5.6.2.1. Key country dynamics
                            5.6.2.2. Regulatory framework/ reimbursement structure
                            5.6.2.3. Competitive scenario
                            5.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
                        5.6.3. France
                            5.6.3.1. Key country dynamics
                            5.6.3.2. Regulatory framework/ reimbursement structure
                            5.6.3.3. Competitive scenario
                            5.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
                        5.6.4. Italy
                            5.6.4.1. Key country dynamics
                            5.6.4.2. Regulatory framework/ reimbursement structure
                            5.6.4.3. Competitive scenario
                            5.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
                        5.6.5. Spain
                            5.6.5.1. Key country dynamics
                            5.6.5.2. Regulatory framework/ reimbursement structure
                            5.6.5.3. Competitive scenario
                            5.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
                        5.6.6. Norway
                            5.6.6.1. Key country dynamics
                            5.6.6.2. Regulatory framework/ reimbursement structure
                            5.6.6.3. Competitive scenario
                            5.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
                        5.6.7. Sweden
                            5.6.7.1. Key country dynamics
                            5.6.7.2. Regulatory framework/ reimbursement structure
                            5.6.7.3. Competitive scenario
                            5.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
                        5.6.8. Denmark
                            5.6.8.1. Key country dynamics
                            5.6.8.2. Regulatory framework/ reimbursement structure
                            5.6.8.3. Competitive scenario
                            5.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
                    5.7. Asia Pacific
                        5.7.1. Japan
                            5.7.1.1. Key country dynamics
                            5.7.1.2. Regulatory framework/ reimbursement structure
                            5.7.1.3. Competitive scenario
                            5.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
                        5.7.2. China
                            5.7.2.1. Key country dynamics
                            5.7.2.2. Regulatory framework/ reimbursement structure
                            5.7.2.3. Competitive scenario
                            5.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
                        5.7.3. India
                            5.7.3.1. Key country dynamics
                            5.7.3.2. Regulatory framework/ reimbursement structure
                            5.7.3.3. Competitive scenario
                            5.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
                        5.7.4. Australia
                            5.7.4.1. Key country dynamics
                            5.7.4.2. Regulatory framework/ reimbursement structure
                            5.7.4.3. Competitive scenario
                            5.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
                        5.7.5. South Korea
                            5.7.5.1. Key country dynamics
                            5.7.5.2. Regulatory framework/ reimbursement structure
                            5.7.5.3. Competitive scenario
                            5.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
                        5.7.6. Thailand
                            5.7.6.1. Key country dynamics
                            5.7.6.2. Regulatory framework/ reimbursement structure
                            5.7.6.3. Competitive scenario
                            5.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
                    5.8. Latin America
                        5.8.1. Brazil
                            5.8.1.1. Key country dynamics
                            5.8.1.2. Regulatory framework/ reimbursement structure
                            5.8.1.3. Competitive scenario
                            5.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
                        5.8.2. Argentina
                            5.8.2.1. Key country dynamics
                            5.8.2.2. Regulatory framework/ reimbursement structure
                            5.8.2.3. Competitive scenario
                            5.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
                    5.9. Middle East & Africa
                        5.9.1. South Africa
                            5.9.1.1. Key country dynamics
                            5.9.1.2. Regulatory framework/ reimbursement structure
                            5.9.1.3. Competitive scenario
                            5.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
                        5.9.2. Saudi Arabia
                            5.9.2.1. Key country dynamics
                            5.9.2.2. Regulatory framework/ reimbursement structure
                            5.9.2.3. Competitive scenario
                            5.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
                        5.9.3. UAE
                            5.9.3.1. Key country dynamics
                            5.9.3.2. Regulatory framework/ reimbursement structure
                            5.9.3.3. Competitive scenario
                            5.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
                        5.9.4. Kuwait
                            5.9.4.1. Key country dynamics
                            5.9.4.2. Regulatory framework/ reimbursement structure
                            5.9.4.3. Competitive scenario
                            5.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Competitive Landscape
                    6.1. Recent Developments & Impact Analysis, By Key Market Participants
                    6.2. Company/Competition Categorization
                    6.3. Vendor Landscape
                        6.3.1. List of key distributors and channel partners
                        6.3.2. Key customers
                        6.3.3. Key company market share analysis, 2024
                        6.3.4. QUEST DIAGNOSTICS
                            6.3.4.1. Company overview
                            6.3.4.2. Financial performance
                            6.3.4.3. Product benchmarking
                            6.3.4.4. Strategic initiatives
                        6.3.5. Abbott
                            6.3.5.1. Company overview
                            6.3.5.2. Financial performance
                            6.3.5.3. Product benchmarking
                            6.3.5.4. Strategic initiatives
                        6.3.6. CLINICAL REFERENCE LABORATORY (CRL), INC.
                            6.3.6.1. Company overview
                            6.3.6.2. Financial performance
                            6.3.6.3. Product benchmarking
                            6.3.6.4. Strategic initiatives
                        6.3.7. LABORATORY CORPORATION OF AMERICA HOLDINGS
                            6.3.7.1. Company overview
                            6.3.7.2. Financial performance
                            6.3.7.3. Product benchmarking
                            6.3.7.4. Strategic initiatives
                        6.3.8. CORDANT HEALTH SOLUTIONS
                            6.3.8.1. Company overview
                            6.3.8.2. Financial performance
                            6.3.8.3. Product benchmarking
                            6.3.8.4. Strategic initiatives
                        6.3.9. LEGACY MEDICAL SERVICES
                            6.3.9.1. Company overview
                            6.3.9.2. Financial performance
                            6.3.9.3. Product benchmarking
                            6.3.9.4. Strategic initiatives
                        6.3.10. DRUGSCAN
                            6.3.10.1. Company overview
                            6.3.10.2. Financial performance
                            6.3.10.3. Product benchmarking
                            6.3.10.4. Strategic initiatives
                        6.3.11. OMEGA LABORATORIES, INC.
                            6.3.11.1. Company overview
                            6.3.11.2. Financial performance
                            6.3.11.3. Product benchmarking
                            6.3.11.4. Strategic initiatives
                        6.3.12. PSYCHEMEDICS CORPORATION
                            6.3.12.1. Company overview
                            6.3.12.2. Financial performance
                            6.3.12.3. Product benchmarking
                            6.3.12.4. Strategic initiatives
                        6.3.13. MILLENNIUM HEALTH, LLC
                            6.3.13.1. Company overview
                            6.3.13.2. Financial performance
                            6.3.13.3. Product benchmarking
                            6.3.13.4. Strategic initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of abbreviation
Table 3 North America drug of abuse testing services market, by region, 2018 - 2030 (USD Million)
Table 4 North America drug of abuse testing services market, by drug, 2018 - 2030 (USD Million)
Table 5 U.S. drug of abuse testing services market, by drug, 2018 - 2030 (USD Million)
Table 6 Canada drug of abuse testing services market, by drug, 2018 - 2030 (USD Million)
Table 7 Mexico drug of abuse testing services market, by drug, 2018 - 2030 (USD Million)
Table 8 Europe drug of abuse testing services market, by drug, 2018 - 2030 (USD Million)
Table 9 Germany drug of abuse testing services market, by drug, 2018 - 2030 (USD Million)
Table 10 UK drug of abuse testing services market, by drug, 2018 - 2030 (USD Million)
Table 11 France drug of abuse testing services market, by drug, 2018 - 2030 (USD Million)
Table 12 Italy drug of abuse testing services market, by drug, 2018 - 2030 (USD Million)
Table 13 Spain drug of abuse testing services market, by drug, 2018 - 2030 (USD Million)
Table 14 Denmark drug of abuse testing services market, by drug, 2018 - 2030 (USD Million)
Table 15 Sweden drug of abuse testing services market, by drug, 2018 - 2030 (USD Million)
Table 16 Norway drug of abuse testing services market, by drug, 2018 - 2030 (USD Million)
Table 17 Asia Pacific drug of abuse testing services market, by drug, 2018 - 2030 (USD Million)
Table 18 China drug of abuse testing services market, by drug, 2018 - 2030 (USD Million)
Table 19 Japan drug of abuse testing services market, by drug, 2018 - 2030 (USD Million)
Table 20 India drug of abuse testing services market, by drug, 2018 - 2030 (USD Million)
Table 21 South Korea drug of abuse testing services market, by drug, 2018 - 2030 (USD Million)
Table 22 Australia drug of abuse testing services market, by drug, 2018 - 2030 (USD Million)
Table 23 Thailand drug of abuse testing services market, by drug, 2018 - 2030 (USD Million)
Table 24 Latin America drug of abuse testing services market, by drug, 2018 - 2030 (USD Million)
Table 25 Brazil drug of abuse testing services market, by drug, 2018 - 2030 (USD Million)
Table 26 Argentina drug of abuse testing services market, by drug, 2018 - 2030 (USD Million)
Table 27 Middle East & Africa drug of abuse testing services market, by drug, 2018 - 2030 (USD Million)
Table 28 South Africa drug of abuse testing services market, by drug, 2018 - 2030 (USD Million)
Table 29 Saudi Arabia drug of abuse testing services market, by drug, 2018 - 2030 (USD Million)
Table 30 UAE drug of abuse testing services market, by drug, 2018 - 2030 (USD Million)
Table 31 Kuwait drug of abuse testing services market, by drug, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Information procurement
Fig. 2 Primary research pattern
Fig. 3 Market research approaches
Fig. 4 Value chain-based sizing & forecasting
Fig. 5 Market formulation & validation
Fig. 6 Pathology Laboratories market segmentation
Fig. 7 Market driver analysis (current & future impact)
Fig. 8 Market restraint analysis (current & future impact)
Fig. 9 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 10 Porter’s five forces analysis
Fig. 11 Drug Of Abuse Testing Services market: drug movement analysis
Fig. 12 Drug Of Abuse Testing Services market: drug outlook and key takeaways
Fig. 13 Alcohol market estimates and forecasts, 2018 - 2030
Fig. 14 Cannabis/Marijuana market estimates and forecasts, 2018 - 2030
Fig. 15 Cocaine market estimates and forecasts, 2018 - 2030
Fig. 16 Opioids market estimates and forecasts, 2018 - 2030
Fig. 17 Amphetamine & methamphetamine market estimates and forecasts, 2018 - 2030
Fig. 18 Other market estimates and forecasts, 2018 - 2030
Fig. 19 Global Drug Of Abuse Testing Services market: Regional outlook and key takeaways
Fig. 20 North America market estimates and forecasts, 2018 - 2030
Fig. 21 U.S. market estimates and forecasts, 2018 - 2030
Fig. 22 Canada market estimates and forecasts, 2018 - 2030
Fig. 23 Mexico market estimates and forecasts, 2018 - 2030
Fig. 24 Europe market estimates and forecasts, 2018 - 2030
Fig. 25 UK market estimates and forecasts, 2018 - 2030
Fig. 26 Germany market estimates and forecasts, 2018 - 2030
Fig. 27 France market estimates and forecasts, 2018 - 2030
Fig. 28 Italy market estimates and forecasts, 2018 - 2030
Fig. 29 Spain market estimates and forecasts, 2018 - 2030
Fig. 30 Denmark market estimates and forecasts, 2018 - 2030
Fig. 31 Sweden market estimates and forecasts, 2018 - 2030
Fig. 32 Norway market estimates and forecasts, 2018 - 2030
Fig. 33 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 34 China market estimates and forecasts, 2018 - 2030
Fig. 35 Japan market estimates and forecasts, 2018 - 2030
Fig. 36 India market estimates and forecasts, 2018 - 2030
Fig. 37 Thailand market estimates and forecasts, 2018 - 2030
Fig. 38 South Korea market estimates and forecasts, 2018 - 2030
Fig. 39 Australia market estimates and forecasts, 2018 - 2030
Fig. 40 Latin America market estimates and forecasts, 2018 - 2030
Fig. 41 Brazil market estimates and forecasts, 2018 - 2030
Fig. 42 Argentina market estimates and forecasts, 2018 - 2030
Fig. 43 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 44 South Africa market estimates and forecasts, 2018 - 2030
Fig. 45 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 46 UAE market estimates and forecasts, 2018 - 2030
Fig. 47 Kuwait market estimates and forecasts, 2018 - 2030
Fig. 48 Market share of key market players- Drug Of Abuse Testing Services market